ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global CD Targeted Bispecific Antibody Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-2E14087
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global CD Targeted Bispecific Antibody Market Research Report 2023
BUY CHAPTERS

Global CD Targeted Bispecific Antibody Market Research Report 2025

Code: QYRE-Auto-2E14087
Report
May 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Aptevo Therapeutics
Affimed NV
Sutro Biopharma
IGM Biosciences
Xencor
Amgen Inc
Astella Pharma
Ben Kang Biopharmaceutical (Shenzhen)
Merus NV
Regeneron Pharmaceuticals
Genentech Usa

CD Targeted Bispecific Antibody Market Size

The global market for CD Targeted Bispecific Antibody was valued at US$ 6085 million in the year 2024 and is projected to reach a revised size of US$ 11390 million by 2031, growing at a CAGR of 9.5% during the forecast period.

CD Targeted Bispecific Antibody Market

CD Targeted Bispecific Antibody Market

A CD-targeted bispecific antibody refers to a type of bispecific antibody designed to target specific cell surface markers known as cluster of differentiation (CD) antigens. Bispecific antibodies are engineered proteins that can simultaneously bind to two different antigens, often on distinct cell types. These antibodies have gained attention for their potential therapeutic applications, including cancer immunotherapy.
Researchers are exploring a broader range of target antigens beyond well-established CD antigens. This includes identifying new cell surface markers specific to certain cancers or disease types, providing additional options for targeted therapies.
This report aims to provide a comprehensive presentation of the global market for CD Targeted Bispecific Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD Targeted Bispecific Antibody.
The CD Targeted Bispecific Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CD Targeted Bispecific Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CD Targeted Bispecific Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of CD Targeted Bispecific Antibody Market Report

Report Metric Details
Report Name CD Targeted Bispecific Antibody Market
Accounted market size in year US$ 6085 million
Forecasted market size in 2031 US$ 11390 million
CAGR 9.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • CD3
  • CD20
  • CD40
  • Others
Segment by Application
  • Biotechnology
  • Laboratory
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Aptevo Therapeutics, Affimed Gmbh, Sutro Biopharma, Igm Biosciences, Xencor, Amgen, Genentech Usa, Astella Pharma, Ben Kang Biopharmaceutical (Shenzhen), Merus, Regeneron Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of CD Targeted Bispecific Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is CD Targeted Bispecific Antibody Market growing?

Ans: The CD Targeted Bispecific Antibody Market witnessing a CAGR of 9.5% during the forecast period 2025-2031.

What is the CD Targeted Bispecific Antibody Market size in 2031?

Ans: The CD Targeted Bispecific Antibody Market size in 2031 will be US$ 11390 million.

Who are the main players in the CD Targeted Bispecific Antibody Market report?

Ans: The main players in the CD Targeted Bispecific Antibody Market are Aptevo Therapeutics, Affimed Gmbh, Sutro Biopharma, Igm Biosciences, Xencor, Amgen, Genentech Usa, Astella Pharma, Ben Kang Biopharmaceutical (Shenzhen), Merus, Regeneron Pharmaceuticals

What are the Application segmentation covered in the CD Targeted Bispecific Antibody Market report?

Ans: The Applications covered in the CD Targeted Bispecific Antibody Market report are Biotechnology, Laboratory, Others

What are the Type segmentation covered in the CD Targeted Bispecific Antibody Market report?

Ans: The Types covered in the CD Targeted Bispecific Antibody Market report are CD3, CD20, CD40, Others

Recommended Reports

Bispecific Antibody Drugs

Targeted Therapies

Antibody Market Landscape

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CD Targeted Bispecific Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CD3
1.2.3 CD20
1.2.4 CD40
1.2.5 Others
1.3 Market by Application
1.3.1 Global CD Targeted Bispecific Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology
1.3.3 Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CD Targeted Bispecific Antibody Market Perspective (2020-2031)
2.2 Global CD Targeted Bispecific Antibody Growth Trends by Region
2.2.1 Global CD Targeted Bispecific Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CD Targeted Bispecific Antibody Historic Market Size by Region (2020-2025)
2.2.3 CD Targeted Bispecific Antibody Forecasted Market Size by Region (2026-2031)
2.3 CD Targeted Bispecific Antibody Market Dynamics
2.3.1 CD Targeted Bispecific Antibody Industry Trends
2.3.2 CD Targeted Bispecific Antibody Market Drivers
2.3.3 CD Targeted Bispecific Antibody Market Challenges
2.3.4 CD Targeted Bispecific Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CD Targeted Bispecific Antibody Players by Revenue
3.1.1 Global Top CD Targeted Bispecific Antibody Players by Revenue (2020-2025)
3.1.2 Global CD Targeted Bispecific Antibody Revenue Market Share by Players (2020-2025)
3.2 Global CD Targeted Bispecific Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CD Targeted Bispecific Antibody Revenue
3.4 Global CD Targeted Bispecific Antibody Market Concentration Ratio
3.4.1 Global CD Targeted Bispecific Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CD Targeted Bispecific Antibody Revenue in 2024
3.5 Global Key Players of CD Targeted Bispecific Antibody Head office and Area Served
3.6 Global Key Players of CD Targeted Bispecific Antibody, Product and Application
3.7 Global Key Players of CD Targeted Bispecific Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CD Targeted Bispecific Antibody Breakdown Data by Type
4.1 Global CD Targeted Bispecific Antibody Historic Market Size by Type (2020-2025)
4.2 Global CD Targeted Bispecific Antibody Forecasted Market Size by Type (2026-2031)
5 CD Targeted Bispecific Antibody Breakdown Data by Application
5.1 Global CD Targeted Bispecific Antibody Historic Market Size by Application (2020-2025)
5.2 Global CD Targeted Bispecific Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CD Targeted Bispecific Antibody Market Size (2020-2031)
6.2 North America CD Targeted Bispecific Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CD Targeted Bispecific Antibody Market Size by Country (2020-2025)
6.4 North America CD Targeted Bispecific Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CD Targeted Bispecific Antibody Market Size (2020-2031)
7.2 Europe CD Targeted Bispecific Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CD Targeted Bispecific Antibody Market Size by Country (2020-2025)
7.4 Europe CD Targeted Bispecific Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CD Targeted Bispecific Antibody Market Size (2020-2031)
8.2 Asia-Pacific CD Targeted Bispecific Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CD Targeted Bispecific Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific CD Targeted Bispecific Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CD Targeted Bispecific Antibody Market Size (2020-2031)
9.2 Latin America CD Targeted Bispecific Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CD Targeted Bispecific Antibody Market Size by Country (2020-2025)
9.4 Latin America CD Targeted Bispecific Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CD Targeted Bispecific Antibody Market Size (2020-2031)
10.2 Middle East & Africa CD Targeted Bispecific Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CD Targeted Bispecific Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa CD Targeted Bispecific Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aptevo Therapeutics
11.1.1 Aptevo Therapeutics Company Details
11.1.2 Aptevo Therapeutics Business Overview
11.1.3 Aptevo Therapeutics CD Targeted Bispecific Antibody Introduction
11.1.4 Aptevo Therapeutics Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.1.5 Aptevo Therapeutics Recent Development
11.2 Affimed Gmbh
11.2.1 Affimed Gmbh Company Details
11.2.2 Affimed Gmbh Business Overview
11.2.3 Affimed Gmbh CD Targeted Bispecific Antibody Introduction
11.2.4 Affimed Gmbh Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.2.5 Affimed Gmbh Recent Development
11.3 Sutro Biopharma
11.3.1 Sutro Biopharma Company Details
11.3.2 Sutro Biopharma Business Overview
11.3.3 Sutro Biopharma CD Targeted Bispecific Antibody Introduction
11.3.4 Sutro Biopharma Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.3.5 Sutro Biopharma Recent Development
11.4 Igm Biosciences
11.4.1 Igm Biosciences Company Details
11.4.2 Igm Biosciences Business Overview
11.4.3 Igm Biosciences CD Targeted Bispecific Antibody Introduction
11.4.4 Igm Biosciences Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.4.5 Igm Biosciences Recent Development
11.5 Xencor
11.5.1 Xencor Company Details
11.5.2 Xencor Business Overview
11.5.3 Xencor CD Targeted Bispecific Antibody Introduction
11.5.4 Xencor Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.5.5 Xencor Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen CD Targeted Bispecific Antibody Introduction
11.6.4 Amgen Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.6.5 Amgen Recent Development
11.7 Genentech Usa
11.7.1 Genentech Usa Company Details
11.7.2 Genentech Usa Business Overview
11.7.3 Genentech Usa CD Targeted Bispecific Antibody Introduction
11.7.4 Genentech Usa Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.7.5 Genentech Usa Recent Development
11.8 Astella Pharma
11.8.1 Astella Pharma Company Details
11.8.2 Astella Pharma Business Overview
11.8.3 Astella Pharma CD Targeted Bispecific Antibody Introduction
11.8.4 Astella Pharma Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.8.5 Astella Pharma Recent Development
11.9 Ben Kang Biopharmaceutical (Shenzhen)
11.9.1 Ben Kang Biopharmaceutical (Shenzhen) Company Details
11.9.2 Ben Kang Biopharmaceutical (Shenzhen) Business Overview
11.9.3 Ben Kang Biopharmaceutical (Shenzhen) CD Targeted Bispecific Antibody Introduction
11.9.4 Ben Kang Biopharmaceutical (Shenzhen) Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.9.5 Ben Kang Biopharmaceutical (Shenzhen) Recent Development
11.10 Merus
11.10.1 Merus Company Details
11.10.2 Merus Business Overview
11.10.3 Merus CD Targeted Bispecific Antibody Introduction
11.10.4 Merus Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.10.5 Merus Recent Development
11.11 Regeneron Pharmaceuticals
11.11.1 Regeneron Pharmaceuticals Company Details
11.11.2 Regeneron Pharmaceuticals Business Overview
11.11.3 Regeneron Pharmaceuticals CD Targeted Bispecific Antibody Introduction
11.11.4 Regeneron Pharmaceuticals Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.11.5 Regeneron Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Aptevo Therapeutics
Affimed NV
Sutro Biopharma
IGM Biosciences
Xencor
Amgen Inc
Astella Pharma
Ben Kang Biopharmaceutical (Shenzhen)
Merus NV
Regeneron Pharmaceuticals
Genentech Usa
List of Tables
 Table 1. Global CD Targeted Bispecific Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of CD3
 Table 3. Key Players of CD20
 Table 4. Key Players of CD40
 Table 5. Key Players of Others
 Table 6. Global CD Targeted Bispecific Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global CD Targeted Bispecific Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global CD Targeted Bispecific Antibody Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global CD Targeted Bispecific Antibody Market Share by Region (2020-2025)
 Table 10. Global CD Targeted Bispecific Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global CD Targeted Bispecific Antibody Market Share by Region (2026-2031)
 Table 12. CD Targeted Bispecific Antibody Market Trends
 Table 13. CD Targeted Bispecific Antibody Market Drivers
 Table 14. CD Targeted Bispecific Antibody Market Challenges
 Table 15. CD Targeted Bispecific Antibody Market Restraints
 Table 16. Global CD Targeted Bispecific Antibody Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global CD Targeted Bispecific Antibody Market Share by Players (2020-2025)
 Table 18. Global Top CD Targeted Bispecific Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD Targeted Bispecific Antibody as of 2024)
 Table 19. Ranking of Global Top CD Targeted Bispecific Antibody Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by CD Targeted Bispecific Antibody Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of CD Targeted Bispecific Antibody, Headquarters and Area Served
 Table 22. Global Key Players of CD Targeted Bispecific Antibody, Product and Application
 Table 23. Global Key Players of CD Targeted Bispecific Antibody, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global CD Targeted Bispecific Antibody Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global CD Targeted Bispecific Antibody Revenue Market Share by Type (2020-2025)
 Table 27. Global CD Targeted Bispecific Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global CD Targeted Bispecific Antibody Revenue Market Share by Type (2026-2031)
 Table 29. Global CD Targeted Bispecific Antibody Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global CD Targeted Bispecific Antibody Revenue Market Share by Application (2020-2025)
 Table 31. Global CD Targeted Bispecific Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global CD Targeted Bispecific Antibody Revenue Market Share by Application (2026-2031)
 Table 33. North America CD Targeted Bispecific Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America CD Targeted Bispecific Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America CD Targeted Bispecific Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe CD Targeted Bispecific Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe CD Targeted Bispecific Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe CD Targeted Bispecific Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific CD Targeted Bispecific Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific CD Targeted Bispecific Antibody Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific CD Targeted Bispecific Antibody Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America CD Targeted Bispecific Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America CD Targeted Bispecific Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America CD Targeted Bispecific Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa CD Targeted Bispecific Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa CD Targeted Bispecific Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa CD Targeted Bispecific Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Aptevo Therapeutics Company Details
 Table 49. Aptevo Therapeutics Business Overview
 Table 50. Aptevo Therapeutics CD Targeted Bispecific Antibody Product
 Table 51. Aptevo Therapeutics Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
 Table 52. Aptevo Therapeutics Recent Development
 Table 53. Affimed Gmbh Company Details
 Table 54. Affimed Gmbh Business Overview
 Table 55. Affimed Gmbh CD Targeted Bispecific Antibody Product
 Table 56. Affimed Gmbh Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
 Table 57. Affimed Gmbh Recent Development
 Table 58. Sutro Biopharma Company Details
 Table 59. Sutro Biopharma Business Overview
 Table 60. Sutro Biopharma CD Targeted Bispecific Antibody Product
 Table 61. Sutro Biopharma Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
 Table 62. Sutro Biopharma Recent Development
 Table 63. Igm Biosciences Company Details
 Table 64. Igm Biosciences Business Overview
 Table 65. Igm Biosciences CD Targeted Bispecific Antibody Product
 Table 66. Igm Biosciences Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
 Table 67. Igm Biosciences Recent Development
 Table 68. Xencor Company Details
 Table 69. Xencor Business Overview
 Table 70. Xencor CD Targeted Bispecific Antibody Product
 Table 71. Xencor Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
 Table 72. Xencor Recent Development
 Table 73. Amgen Company Details
 Table 74. Amgen Business Overview
 Table 75. Amgen CD Targeted Bispecific Antibody Product
 Table 76. Amgen Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
 Table 77. Amgen Recent Development
 Table 78. Genentech Usa Company Details
 Table 79. Genentech Usa Business Overview
 Table 80. Genentech Usa CD Targeted Bispecific Antibody Product
 Table 81. Genentech Usa Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
 Table 82. Genentech Usa Recent Development
 Table 83. Astella Pharma Company Details
 Table 84. Astella Pharma Business Overview
 Table 85. Astella Pharma CD Targeted Bispecific Antibody Product
 Table 86. Astella Pharma Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
 Table 87. Astella Pharma Recent Development
 Table 88. Ben Kang Biopharmaceutical (Shenzhen) Company Details
 Table 89. Ben Kang Biopharmaceutical (Shenzhen) Business Overview
 Table 90. Ben Kang Biopharmaceutical (Shenzhen) CD Targeted Bispecific Antibody Product
 Table 91. Ben Kang Biopharmaceutical (Shenzhen) Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
 Table 92. Ben Kang Biopharmaceutical (Shenzhen) Recent Development
 Table 93. Merus Company Details
 Table 94. Merus Business Overview
 Table 95. Merus CD Targeted Bispecific Antibody Product
 Table 96. Merus Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
 Table 97. Merus Recent Development
 Table 98. Regeneron Pharmaceuticals Company Details
 Table 99. Regeneron Pharmaceuticals Business Overview
 Table 100. Regeneron Pharmaceuticals CD Targeted Bispecific Antibody Product
 Table 101. Regeneron Pharmaceuticals Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
 Table 102. Regeneron Pharmaceuticals Recent Development
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. CD Targeted Bispecific Antibody Picture
 Figure 2. Global CD Targeted Bispecific Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global CD Targeted Bispecific Antibody Market Share by Type: 2024 VS 2031
 Figure 4. CD3 Features
 Figure 5. CD20 Features
 Figure 6. CD40 Features
 Figure 7. Others Features
 Figure 8. Global CD Targeted Bispecific Antibody Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global CD Targeted Bispecific Antibody Market Share by Application: 2024 VS 2031
 Figure 10. Biotechnology Case Studies
 Figure 11. Laboratory Case Studies
 Figure 12. Others Case Studies
 Figure 13. CD Targeted Bispecific Antibody Report Years Considered
 Figure 14. Global CD Targeted Bispecific Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global CD Targeted Bispecific Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global CD Targeted Bispecific Antibody Market Share by Region: 2024 VS 2031
 Figure 17. Global CD Targeted Bispecific Antibody Market Share by Players in 2024
 Figure 18. Global Top CD Targeted Bispecific Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD Targeted Bispecific Antibody as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by CD Targeted Bispecific Antibody Revenue in 2024
 Figure 20. North America CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America CD Targeted Bispecific Antibody Market Share by Country (2020-2031)
 Figure 22. United States CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe CD Targeted Bispecific Antibody Market Share by Country (2020-2031)
 Figure 26. Germany CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific CD Targeted Bispecific Antibody Market Share by Region (2020-2031)
 Figure 34. China CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America CD Targeted Bispecific Antibody Market Share by Country (2020-2031)
 Figure 42. Mexico CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa CD Targeted Bispecific Antibody Market Share by Country (2020-2031)
 Figure 46. Turkey CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Aptevo Therapeutics Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
 Figure 50. Affimed Gmbh Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
 Figure 51. Sutro Biopharma Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
 Figure 52. Igm Biosciences Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
 Figure 53. Xencor Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
 Figure 54. Amgen Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
 Figure 55. Genentech Usa Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
 Figure 56. Astella Pharma Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
 Figure 57. Ben Kang Biopharmaceutical (Shenzhen) Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
 Figure 58. Merus Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
 Figure 59. Regeneron Pharmaceuticals Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Bispecific Antibody Technology Platform Market Research Report 2025
Bispecific and Trispecific Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bispecific Antibody Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
BiSpecific MAbS Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bispecific Antibodies Drug Market Research Report 2025
Global Bi Specific MAbS Market Research Report 2024
Global Bispecific Antibodies for Cancer Market Insights Forecast to 2030
Global Antibodies Market Research Report 2024
Global T Cell NK Cell Engaging Bispecific Antibodies Market Research Report 2025
Global Bispecific Antibody Development Platform Market Research Report 2024
Global Secondary Antibody Market Research Report 2024
Global Research Antibodies Market Research Report 2025
Global Secondary Antibodies Market Research Report 2025
Global Antibody Array Market Research Report 2025
Global Double Barreled Antibodies Drug Market Research Report 2025
Global Epitope Tag Antibody Market Research Report 2024
Global BCMA CD3 Bispecific Antibody Market Research Report 2024
Global Chimeric Antibody Market Research Report 2025
Global Antibody Microarrays Market Research Report 2025
Global Antibody and Recombinant Protein CDMO Market Research Report 2025

RELATED REPORTS

Global Cephalosporin APIs and Cephalosporin Intermediates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19G16926
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ELISA Immunoassay Plates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7Z17064
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ready-to-Use ELISA Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20P20045
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Moxidectin Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3Z19977
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions